Shanghai Pharmaceuticals
Shanghai Pharmaceuticals Holding Co., Ltd., commonly referred to as Shanghai Pharmaceuticals, is a leading player in the pharmaceutical industry, headquartered in Shanghai, China. Founded in 1994, the company has established a strong presence in both domestic and international markets, focusing on research and development, manufacturing, and distribution of a wide range of pharmaceutical products. With a diverse portfolio that includes prescription drugs, over-the-counter medications, and active pharmaceutical ingredients, Shanghai Pharmaceuticals is recognised for its commitment to quality and innovation. The company has achieved significant milestones, including strategic partnerships and expansions into various therapeutic areas, solidifying its position as a key contributor to global healthcare. Notably, Shanghai Pharmaceuticals has been acknowledged for its robust supply chain and extensive distribution network, enhancing its market competitiveness.
DitchCarbon Score
How does Shanghai Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shanghai Pharmaceuticals's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shanghai Pharmaceuticals's reported carbon emissions
Shanghai Pharmaceuticals, headquartered in CN, currently does not have publicly available data on its carbon emissions, including specific figures for Scope 1, 2, or 3 emissions. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. As the pharmaceutical industry increasingly prioritises sustainability, Shanghai Pharmaceuticals may need to enhance its transparency and set measurable targets to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shanghai Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
